PTC Therapeutics reported $206.31M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Cytokinetics USD 68.54M 54.6M Jun/2025
Daiichi Sankyo JPY 518.54B 61.41B Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Ironwood Pharmaceuticals USD 2.13M 1.11M Dec/2024
Novartis USD 4.51B 245M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
TG Therapeutics 134.02M 92.06M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025
Xencor USD 18.53M 2.34M Jun/2025